Skip to main content
The Making of Medicine

Tag: cancer (Page 4)

Holly Davis coordinates multi-site clinical trials for UVA.
Overseeing Multi-Center Clinical Trials
6/26/2019

I'd like to introduce you to Holly Davis, the UVA employee I’ve known the longest. That’s because she’s my cousin. We grew up like brother and sister in far Southwest Virginia, and we have the accent to prove it.

Researchers Lelisa F. Gemta (left) and Timothy Bullock have determined why killer T cells can be so helpless against cancer. Their discovery could help doctors make the immune cells much more effective against cancer.
Making Immune Cells Better Cancer Killers
2/28/2019

Our Timothy Bullock, PhD, and his team have discovered a defect in immune cells known as “killer T cells” that explains why they struggle to destroy cancer tumors. By fixing this defect, scientists could make the cells much better at killing cancer cells.

Anindya Duttta, PhD, holds his hands open wide while standing in a white lab coat in his lab.
HPV Discovery Opens Door to New Cancer Treatments
12/12/2018

Anindya Dutta and his colleagues have identified a substance that is essential for the sexually transmitted virus to cause cancer. That discovery could lead to new treatments for HPV cancers.

Shayna Showalter, MD, a breast cancer surgeon, and her husband, Tim Showalter, MD, a radiation oncologist, stand in front of a large machine.
A Husband and Wife Working to Improve Breast Cancer Care
12/3/2018

Tim and Shayna Showalter, who are married, have developed a technique called Precision Breast Intraoperative Radiation, which aims to improve on conventional breast IORT by making it more targeted, more powerful, more personalized and, hopefully, more effective.

Daniel
One of 2017’s Top 10 Clinical Research Achievements!
4/18/2018

Here's a well-earned recognition: Our Daniel "Trey" Lee's pioneering work in battling pediatric leukemia has been honored as one of 2017’s top 10 Clinical Research Achievements by the Clinical Research Forum. Dr. Lee’s research weaponizes immune cells, known as T cells, in pediatric and young adult clinical trial participants to…

Subscribe